Clinical evaluation of a powder of quality elk velvet antler
Moreau M, Dupuis J, Bonneau NH, Lecuyer M.
The Companion Animal Research Group, Faculte de Medecine veterinaire, Universite de Montreal, 3200 Sicotte, P.O. Box 5000, St-Hyacinthe Quebec J2S 7C6. m.moreau@umontreal.ca
A powder of quality elk velvet antler (QEVA) was evaluated on client-owned dogs with osteoarthrosis (OA) in a clinical, double-blind, and placebo-controlled study. Thirteen dogs received a placebo for 30 days and then QEVA for 60 days. Twenty-five other dogs received QEVA for 60 days. Gait analysis measured with a force plate, clinical signs assessed by an orthopedic surgeon, performances in daily life activities and vitality assessed by the owners, and complete blood analyses were obtained at days 0, after 30 days of placebo and/or 60 days of QEVA. On placebo, the 13 dogs did not show significant improvement (P < 0.05); however, their gait, their performances in daily life activities, and their vitality were significantly improved on QEVA, based on changes in values exceeding those observed when placebo was administered. The 25 dogs on QEVA for 60 days showed similar improvements. No clinical changes were revealed on blood analyses. Administration of QEVA was effective in alleviating the condition in arthritic dogs.
PMID: 15025149 [PubMed - indexed for MEDLINE]
SEE ENTIRE CLINICAL EVALUATION
A Summary of Research on Velvet Antler Dietary Supplements
More than 50 million North Americans suffer from the debilitating pain of osteoarthritis and joint injuries, and many older household pets also experience joint inflammation and lack of mobility due to arthritic conditions. Ironically, most commonly prescribed anti-inflammatory drugs actually contribute to joint degeneration, and also risk a host of other potentially dangerous side effects.
A review of literature related to the use of velvet antler products as an alternative to drugs provides compelling evidence to support the claim that compounds in velvet antler may be significantly more effective and longer-lasting than many conventional prescription and non-prescription drugs for relief of the symptoms of osteoarthritis.
SEE ENTIRE ARTICLE
